- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Changes in Criteria for Indication of Deceased Donor Liver Transplant Recipients
-
- Ueda Yoshihide
- Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine
-
- Ogura Yasuhiro
- Department of Transplantation Surgery, Nagoya University Hospital
-
- Ueno Yoshiyuki
- Department of Gastroenterology, Yamagata University School of Medicine
-
- Kuramitsu Kaori
- Japan Organ Transplant Network
-
- Sakamoto Seisuke
- Organ Transplantation Center, National Center for Child Health and Development
-
- Hibi Taizo
- Department of Pediatric Surgery and Transplantation, Kumamoto University Graduate School of Medical Sciences
-
- Ohdan Hideki
- Department of Gastroenterological and Transplant Surgery, Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University
Bibliographic Information
- Other Title
-
- 脳死肝移植希望者（レシピエント）適応基準の変更
- ノウシ カン イショク キボウシャ(レシピエント)テキオウ キジュン ノ ヘンコウ
Search this article
Description
<p>Strict indication and selection criteria for deceased donor liver transplantation have been established as "Indication criteria for deceased donor liver transplant recipients and related selection criteria." The number of deceased donor liver transplant donors exceeded 100 in 2023. Accordingly, the indication criteria for deceased donor liver transplant recipients have changed since January 2024. First, the eligibility evaluation for deceased donor liver transplantation for decompensated liver failure was changed from a Child-Pugh score ≥10 points to ≥7 points. Therefore, the number of deceased donor liver transplant recipients with hepatocellular carcinoma is expected to increase. Second, deceased donor liver transplantation was indicated in cases of early graft failure occurring less than 1 year after living or deceased donor liver transplantation. Investigation of the impact of deceased donor liver transplantation for other liver diseases and the prognosis of liver transplantation for early graft failure is necessary. When treating a patient who is expected to be at the limit of medical treatment, reviewing these criteria and considering whether liver transplantation is indicated are necessary. We hope that maximum number of patients with end-stage liver disease will recover through liver transplantation by having doctors check the information on liver transplantation on the Japan Society of Hepatology website.</p>
Journal
-
- Kanzo
-
Kanzo 65 (6), 277-283, 2024-06-01
The Japan Society of Hepatology